Displaying drugs 12651 - 12675 of 14436 in total
Exon 55 specific phosphorothioate oligonucleotide
Investigational
Human allogeneic bone marrow derived osteoblastic cells
Investigational
Recombinant human galactocerebrosidase
Investigational
Recifercept
Investigational
Apc001PE
Investigational
Haptoglobulin (human)
Investigational
GIVI-MPC
GIVI-MPC is a therapy that uses human-induced pluripotent stem cell-derived myogenic progenitor cells.
Investigational
Human umbilical tissue derived cells
Investigational
CEQ508
CEQ508 is a Live Attenuated E. Coli Expressing Beta Catenin ShRNA currently being investigated to treat Familial Adenomatous Polyposis.
Investigational
pGM169/GL67A
Investigational
Engensis
Investigational
IR-901
Investigational
Lexanersen
Lexanersen is an antisense oligonucleotide under investigation for use as a disease-modifying therapy in Huntington's disease.
Investigational
OPC1
OPC1 is an oligodendrocyte progenitor cell therapy being investigated for the treatment of acute spinal cord injury.
Investigational
AP-101
AP-101 is a recombinant human antibody directed against human misfolded superoxide dismutase 1.
Investigational
OT-15
Investigational
ABO-201
Investigational
Human ciliary neurotrophic factor, recombinant (E. coli)
Investigational
Tonabacase
Investigational
C-Alpha-stx1
Investigational
Tabituximab barzuxetan yttrium Y-90
A version of tabituximab barzuxetan radiolabeled with yttrium-90.
Investigational
Yttrium Y-90 Labetuzumab
Investigational
Allogenic bone marrow-derived mesenchymal stem cells
Investigational
Displaying drugs 12651 - 12675 of 14436 in total